US Patent Issued to STINGRAY THERAPEUTICS on Sept. 22 for "Imidazole compounds as inhibitors of ENPP1" (California, Arizona Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,963, issued on Sept. 22, was assigned to STINGRAY THERAPEUTICS INC. (Houston).

"Imidazole compounds as inhibitors of ENPP1" was invented by Srinivas Rao Kasibhatla (San Diego), Sunil Sharma (Phoenix), Mohan Kaadige (Scottsdale, Ariz.), Alexis Weston (Phoenix) and Trason Thode (Phoenix).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds having activity as inhibitors of ENPP1 are provided. The compounds have the following structure (I): or a pharmaceutically acceptable salt, tautomer, stereoisomer, or prodrug thereof, wherein L, R1, R2a, R2b, R2c, R2d, R2e and n are as defined herein. This disclosure provides methods associated with preparation ...